Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Herlev Hospital
Twenty outpatients with Chronic Obstructive Lung Disease (COPD) and secondary pulmonary hypertension are treated in a cross-over design with Tadalafil or placebo for 4 weeks. Primary effect parameter is 6 min. walking test.
Age
45–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of Chronic obstructive lung disease
You may not be if
Patients with asthma
Clareo Health | Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
